X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
X4 Pharmaceuticals announced the issuance of inducement stock option awards totaling 32,000 shares to newly hired employees under its 2019 Inducement Equity Incentive Plan, approved by its Compensation Committee and compliant with Nasdaq Listing Rule 5635(c)(4). The options have a 10-year term, an exercise price matching the stock's closing price o…